首页> 外国专利> Crystal forms of (F, G, h, I and K salts addition of imatinib mesylate, Pharmaceutical compositions containing them and the use thereof in the preparation of a Medicament for the treatment of tumors and various types of Leukemia.

Crystal forms of (F, G, h, I and K salts addition of imatinib mesylate, Pharmaceutical compositions containing them and the use thereof in the preparation of a Medicament for the treatment of tumors and various types of Leukemia.

机译:甲磺酸伊马替尼的(F,G,h,I和K盐的晶体形式,含有它们的药物组合物及其在制备用于治疗肿瘤和各种​​类型白血病的药物中的用途。

摘要

The Crystal form Crystal form - F - G - H, Crystal form, Crystal Form I and form Crystal - k metansulfonico acid Addition Salt of 4 - (4 - methyl - 1 - methyl - piperazin) - N - [4 - Methyl 3 - (4 - (pyridin-3-yl) - pyrimidine - 2 - ilamino) phenyl] - benzamide, farmacu00e9utic compositions As containing these Crystal forms,Its use in the preparation of a Medicament for the treatment of diseases such as chronic myeloid leukemia, acute Lymphocytic Leukemia (all) and glioblastoma multiforme.
机译:晶体形式晶体形式-F-G-H,晶体形式,晶体形式I和晶体形式-甲磺酸钾盐4-(4--甲基-1-甲基-哌嗪)-N-[4-甲基3- (4-(吡啶-3-基)-嘧啶-2-2-氨基氨基)苯基]-苯甲酰胺,farmac u00e9utic组合物由于含有这些晶型,其用于制备用于治疗诸如慢性髓性白血病的疾病的药物,急性淋巴细胞白血病(全部)和多形性胶质母细胞瘤。

著录项

  • 公开/公告号AR057923A1

    专利类型

  • 公开/公告日2007-12-26

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;

    申请/专利号AR2006P105173

  • 发明设计人

    申请日2006-11-23

  • 分类号C07D401/04;A61K31/506;A61P35/02;C07D213/38;C07D239/42;C07D401/04;

  • 国家 AR

  • 入库时间 2022-08-21 20:08:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号